🔓
Sign in as a Member to unlock the full view of S.3958. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$29.99/mo already a Member? Sign in →
S.3958 · 118TH CONGRESS

Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2024

Status
Dead
Official Source
Investability
48/100
Stage
COMMITTEE
Related Bills
1
Full Text
3,882 chars
Alive
No

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Action Timeline

2024-03-14
Introduced in Senate
2024-03-14
Read twice and referred to the Committee on Veterans' Affairs.

Frequently Asked Questions

Did S.3958 pass?
S.3958 did not pass and is no longer active. Final stage: COMMITTEE.

Full Bill Text

118 S3958 IS: Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2024 U.S. Senate 2024-03-14 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. II 118th CONGRESS 2d Session S. 3958 IN THE SENATE OF THE UNITED STATES March 14, 2024 Mr. Tester (for himself and Mr. Rubio ) introduced the following bill; which was read twice and referred to the Committee on Veterans' Affairs A BILL To require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving as members of the Armed Forces, and for other purposes. 1. Short title This Act may be cited as the Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2024 . 2. Research on diagnosis and treatment of health conditions of descendants of individuals exposed to toxic substances while serving in Armed Forces (a) In general Subsection (b) of section 501 of the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 ( Public Law 117–168 ) is amended by adding at the end the following new paragraph: (3) Establish Federal interagency task forces to conduct collaborative research activities. . (b) Reporting Subsection (c) of such section is amended by striking paragraphs (2) and (3) and inserting the following: (2) Not later than two years after the date of the enactment of this Act— (A) a report containing a description of the collaborative research activities identified by the Working Group under subsection (b); (B) the findings of the members of the Working Group with respect to the collaborative research activities described in subparagraph (A); (C) the strategic plan developed, by the Working Group under subsection (b); and (D) such recommendations as the Working Group may have for legislative or administrative action to improve collaborative research activities among the members of the Working Group. (3) Not less frequently than annually during the five-year period covered by the strategic plan developed under subsection (b)— (A) a summary of the collaborative research activities carried out by the members of the Working Group and the findings of the members with respect to such research activities; (B) a progress report on implementation of the strategic plan developed by the Working Group under subsection (b); and (C) such recommendations as the Working Group may have for legislative or administrative action to improve collaborative research activities among members of the Working Group. . (c) Research requirements Such section is amended— (1) by redesignating subsections (c) through (e) as subsections (d) through (f), respectively; (2) in subsection (e), as redesignated by paragraph (1), by striking under subsection (c) and inserting under subsection (d) ; and (3) by inserting after subsection (b) the following new subsection (c): (c) Requirements relating to certain research on impacts to descendants The Working Group and the Agency for Toxic Substances and Disease Registry shall— (1) establish an interagency task force to conduct research on the diagnosis and treatment of health conditions of descendants of toxic-exposed veteran (as defined in section 101 of title 38, United States Code); and (2) maintain a publicly available website with information on the activities and findings of the Agency under subparagraph (A), including a review of all relevant data to determine the strength of evidence for a positive association between a health condition researched and a toxic exposure risk activity (as defined in section 1710(e)(4) of title 38, United States Code) based on the categories set forth under section 1173(c)(2) of title 38, United States Code. .
🔒 GovGreed Pro · Trading Intelligence on S.3958 Get Access — $29.99/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-11-17. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]